Financial Performance - In 2023, the company achieved a revenue of 1.4 billion RMB, representing a year-on-year growth of 16.04% despite a significant drop in order volume due to clients entering a destocking phase[6]. - In 2024, the company expects to surpass 1.798 billion RMB in revenue and achieve a net profit of 215 million RMB, both setting historical highs[9]. - The company's operating revenue for 2024 reached ¥1,797,586,628.90, representing a 34.41% increase compared to ¥1,337,363,156.74 in 2023[33]. - Net profit attributable to shareholders for 2024 was ¥215,118,666.29, up 108.34% from ¥103,255,134.65 in 2023[33]. - The basic earnings per share for 2024 increased to ¥1.18, a rise of 110.71% compared to ¥0.56 in 2023[33]. - The total assets at the end of 2024 were ¥2,195,357,433.26, reflecting a 10.81% growth from ¥1,981,188,593.76 at the end of 2023[33]. - The net cash flow from operating activities for 2024 was ¥222,938,812.79, which is a 10.12% increase from ¥202,442,650.52 in 2023[33]. - The company reported a weighted average return on equity of 11.76% for 2024, up from 5.70% in 2023, indicating improved profitability[33]. - The net profit after deducting non-recurring gains and losses for 2024 was ¥191,434,288.00, a 75.09% increase from ¥109,332,444.12 in 2023[33]. - The fourth quarter of 2024 saw a net profit of ¥64,186,988.58, showing consistent quarterly growth throughout the year[38]. Market Position and Strategy - The company maintains a market share of over 30% in the total export value of similar domestic products, solidifying its position as a core supplier in the international market[11]. - The company aims to accelerate domestic market expansion in response to increased tariffs, aligning with national policies to boost domestic demand[12]. - The company plans to continue expanding its market presence and investing in new product development to sustain growth[33]. - The company operates primarily in the disposable hygiene care products and non-woven fabric sector, with pet hygiene products accounting for 94.02% of revenue[43]. - The company’s sales are primarily directed towards international markets, with significant sales in the US, Japan, and Europe, where the market for pet disposable hygiene products is well-established[87]. - The company has over 20 years of experience in the production and sales of pet hygiene products, focusing on high quality and steady development, with products sold in nearly 40 countries including the US, Japan, and Canada[82]. Product Development and Innovation - The company has developed over 1,000 functional pet care products, focusing on core functions such as antibacterial, quick-drying, and deodorizing[11]. - The company plans to continue its commitment to innovation and quality in pet hygiene products, marking its 35th anniversary in 2025[15]. - The company has completed several R&D projects, including the development of eco-friendly pet hygiene products and odor-absorbing pads, aimed at enhancing product comfort and market competitiveness[115]. - The company aims to enhance its product structure and market competitiveness through the application of new materials and innovative designs in its R&D initiatives[115]. - The company has a strong focus on innovation, continuously exploring market trends and product dimensions in the pet hygiene sector[92]. Investment and Expansion Plans - The company plans to invest in a wholly-owned subsidiary in Cambodia, which is expected to commence production by the end of April 2025, enhancing its global capacity strategy[9]. - The company aims to achieve an annual production capacity of 4.6 billion pet pads and 200 million pet pants by 2025, aiming to enhance production efficiency and market share[153]. - The first overseas production base will be established in Cambodia by 2025, with an expected annual production capacity of 270 million pet pads, enhancing global trade risk management[153]. Financial Management and Cost Control - The total cost of goods sold for disposable pet hygiene products in 2024 reached ¥1,339,793,977, representing a 30.28% increase from ¥1,028,378,745 in 2023[108]. - Direct materials for disposable pet hygiene products accounted for 77.15% of the total cost in 2024, up from 76.32% in 2023, with a total amount of ¥1,114,677,188, reflecting a 31.60% increase[108]. - The company reported a 16.72% increase in sales expenses, totaling ¥31,602,833.91 in 2024 compared to ¥27,075,293.50 in 2023[114]. - The company has strengthened cost control and management throughout the project implementation process[142]. Risk Management - The company is exposed to exchange rate fluctuations, primarily using USD for exports, which may impact profitability[157]. - Changes in export tax rebate policies could increase costs and affect the company's export performance[157]. - The company is monitoring international market conditions, as changes in trade policies could impact its business operations[157]. - The company faces labor cost risks as wages continue to rise, which may impact its competitiveness in international markets[156]. - Raw material costs account for over 80% of the company's main business costs, exposing it to risks from price fluctuations[155]. Corporate Governance and Compliance - The company has established a complete internal audit system, with an internal audit department reporting to the board's audit committee[165]. - The company maintains independence in assets, personnel, finance, and operations from its controlling shareholder[166]. - The company has a robust investor relations management system, utilizing multiple channels for communication with investors[165]. - The company ensures fair treatment of all shareholders, particularly minority shareholders, through effective communication channels[162]. - The company has disclosed its decisions and changes in funding allocation through official announcements, ensuring compliance with regulatory requirements[147]. Employee Management and Development - The company has implemented a training program to enhance employee skills and ensure the achievement of operational goals[198]. - The company has a total of 1,531 employees, with 1,098 in production, 75 in sales, 93 in technical roles, 14 in finance, and 251 in administration[196]. - The company has established a comprehensive training system to improve team quality and operational efficiency[198].

Financial Performance - The company's revenue for Q1 2025 reached ¥485,466,355.52, representing a 26.56% increase compared to ¥383,600,696.74 in the same period last year[5] - Net profit attributable to shareholders was ¥54,092,206.44, up 27.96% from ¥42,271,307.81 year-over-year[5] - Basic earnings per share increased by 26.09% to ¥0.29, up from ¥0.23 in the previous year[5] - The gross profit margin improved, with total profit amounting to ¥71,305,554.08, reflecting a 26.35% increase from ¥56,435,301.05 year-over-year[11] - The company experienced a 40.99% increase in net profit after deducting non-recurring gains and losses, reaching ¥50,172,338.90 from ¥35,586,809.77 in the previous year[5] - Total operating revenue for the current period reached ¥485,466,355.52, an increase of 26.6% compared to ¥383,600,696.74 in the previous period[22] - Net profit for the current period was ¥54,092,206.44, representing a 27.9% increase from ¥42,271,307.81 in the previous period[23] - Earnings per share (EPS) for the current period was ¥0.29, compared to ¥0.23 in the previous period[23] Cash Flow and Assets - The net cash flow from operating activities surged by 112.68% to ¥72,223,328.48, compared to ¥33,958,474.36 in Q1 2024[5] - Cash and cash equivalents increased by 244.19% to ¥80,485,810.91, compared to a decrease of ¥55,819,553.82 in Q1 2024[12] - Total current assets increased to 1,538,398,948.16 RMB from 1,449,713,668.81 RMB[19] - Cash and cash equivalents at the end of the period amounted to 414,742,256.24 RMB, up from 328,867,886.22 RMB[19] - The net increase in cash and cash equivalents for the period was CNY 80,485,810.91, compared to a decrease of CNY 55,819,553.82 in the previous period[25] - The ending balance of cash and cash equivalents was CNY 377,235,775.23, up from CNY 213,775,602.79, indicating a growth of 76.7%[25] Investments and Subsidiaries - The company reported a significant increase in investment income, which rose by 306.72% to ¥9,234,742.13, compared to ¥2,270,546.65 in the same quarter last year[10] - The company established a wholly-owned subsidiary in Cambodia with an investment of $3 million, named Cambodian Huasheng Hygiene Products Co., Ltd.[16] Shareholder Information - The total number of common shareholders at the end of the reporting period is 17,564[14] - The largest shareholder, Gao Fuzhong, holds 31.42% of the shares, totaling 58,101,343 shares[14] Share Repurchase - The company approved a share repurchase plan with a total budget of up to 40 million RMB, targeting a repurchase price not exceeding 26.00 RMB per share[17] - The first share repurchase was executed on April 16, 2025, with 100,000 shares bought back at an average price of 16.62 RMB per share, totaling 1,663,400 RMB[18] Liabilities and Assets - Total assets as of March 31, 2025, were ¥2,291,055,344.25, a 4.36% increase from ¥2,195,357,433.26 at the end of the previous year[5] - Total liabilities rose to ¥402,550,267.45, up from ¥362,159,659.16, indicating an increase of 11.1%[21] - The company’s total liabilities decreased by 30.91% in contract liabilities, indicating a reduction in advance payments received[9] Research and Development - Research and development expenses were ¥4,579,508.62, a decrease of 8.8% from ¥5,019,996.21 in the previous period[22] Accounting Standards - The company did not undergo an audit for the first quarter report[26] - The company plans to implement new accounting standards starting from 2025[26]

依依股份(001206.SZ)发布2024年年度报告，公司实现 营业收入17.98亿元，同比增长34.41%； 净利润 2.15亿元，同比增长108.34%。公司拟向全体股东每10股派发现金红利3.7元（含税）。 ...

国新证券股份有限公司 关于天津市依依卫生用品股份有限公司 2024 年度募集资金存放与使用情况的核查意见 国新证券股份有限公司（以下简称"国新证券"）作为天津市依依卫生用品 股份有限公司（以下简称"依依股份"或"公司"）首次公开发行股票并上市及 持续督导的保荐机构，根据《证券发行上市保荐业务管理办法》《深圳证券交易 所股票上市规则》（以下简称"股票上市规则"）《深圳证券交易所上市公司自律 监管指引第 1 号——主板上市公司规范运作》（以下简称"《自律监管指引第 1 号》"）《深圳证券交易所上市公司自律监管指引第 13 号——保荐业务》（以下简 称"《自律监管指引第 13 号》"）《上市公司监管指引第 2 号——上市公司募集资 金管理和使用的监管要求》（以下简称"《上市公司监管指引第 2 号》"）等有关规 定，对依依股份 2024 年度募集资金存放与使用情况进行了核查，核查情况及核 查意见如下： 一、募集资金基本情况 二、募集资金存放和管理情况 为了规范募集资金的管理和使用，保护投资者权益，公司依照中国证监会《上 市公司监管指引第 2 号》等文件的有关规定，结合公司实际情况，制定了《天津 市依依卫生用品股份有限 ...

天津市依依卫生用品股份有限公司 审 计 报 告 大信审字[2025]第 1-00386 号 大信会计师事务所(特殊普通合伙) WUYIGE CERTIFIED PUBLIC ACCOUNTANTS LLP. 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://n.ww.go.gov.cn）"进行评 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://a.mof.gov.cn）" 进行评 学院国际大厦 22 层 2206 WUYIGE Certified Public Accountants.LLP 淀区知春路 1 号 Room 2206 22/F,Xueyuan International Tower No.1 Zhichun Road.Haidian Dist. Beijing,China,100083 电话 Telephone: +86(10) 82330558 +86 (10) 82327668 传真 Fax · www.daxincna.com.cn lx til- Internet. 审计报告 大信审字[2025]第 1-00386 号 天津市依依卫生用品股份 ...

天津市依依卫生用品股份有限公司 募集资金存放与实际使用情况 审核 报 告 大信专审字[2025]第 1-00386 号 大信会计师事务所(特殊普通合伙) WUYIGE CERTIFIED PUBLIC ACCOUNTANTS LLP. 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://acc.mof.gov.cn）"进行查! WUYIGE Certified Public Accountants.LLP 路 1 号 Room 2206 22/F.Xuevuan International Tower 22 层 2206 No.1 Zhichun Road, Haidian Dist. Beijing.China.100083 募集资金存放与实际使用情况审核报告 大信专审字[2025]第 1-00386 号 天津市依依卫生用品股份有限公司全体股东: 我们接受委托,对后附的天津市依依卫生用品股份有限公司(以下简称"贵公司")《2024 年度募集资金存放与实际使用情况的专项报告》（以下简称"募集资金存放与实际使用情况 专项报告"进行了审核。 一、董事会的责任 按照中国证券监督管理委员会《上市公 ...

天津市依依卫生用品股份有限公司 非经营性资金占用及其他关联资金往来情况汇总表的 大信会计师事务所(特殊普通合伙) 专项审计报告 大信专审字[2025]第 1-00387 号 WUYIGE CERTIFIED PUBLIC ACCOUNTANTS LLP. 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://acc.mof.gov.cn）"进行查 报告编码:] 十信会计师事务所 邮编 100083 WUYIGE Certified Public Accountants.LLP 京市海淀区知春路 1 号 Room 2206 22/F,Xueyuan International Tower 传真 Fax: 学院国际大厦 22 层 2206 No.1 Zhichun Road, Haidian Dist. Beijing,China,100083 中证 Telenhone · 网址 Internet: +86 (10) 82330558 +86 (10) 82327668 www.daxincpa.com.cn 非经营性资金占用及其他关联资金往来情况汇总表的 专项审计报告 大信专审字[2025]第 ...

天津市依依卫生用品股份有限公司 内控审计报告 大信审字[2025]第 1-00388 号 大信会计师事务所（特殊普通合伙） WUYIGE CERTIFIED PUBLIC ACCOUNTANTS LLP. 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://w.gsf/file 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://z WUYIGE Certified Public Accountants.LLP 春路 1 号 Room 2206 22/F,Xueyuan International Tower 传真 Fax: 22 层 2206 No.1 Zhichun Road, Haidian Dist. Beijing,China,100083 由 i. Telenhone · 网址 Internet: +86 (10) 82330558 +86 (10) 82327668 www.daxincpa.com.cn 内部控制审计报告 大信审字[2025]第 1-00388 号 天津市依依卫生用品股份有限公司全体股东: 按照《企业内部控制审计指引》及中国注册会计师执业 ...

本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 天津市依依卫生用品股份有限公司（以下简称"公司"）于 2025 年 4 月 11 日召开第三 届董事会第十九次会议，逐项审议通过了《关于回购公司股份方案的议案》，同意公司使用 自有资金以集中竞价交易方式回购公司发行的人民币普通股（A 股）用于股权激励或员工 持股计划。本次回购资金总额上限为 4,000 万元（含），回购资金总额下限为 2,000 万元（含）。 回购股份的价格为不超过人民币 26.00 元/股，若按照回购股份价格上限 26.00 元/股测算， 本次回购股份数量区间为769,230股至1,538,461股，占公司目前总股本比例的区间为0.4160% 至 0.8321%。具体回购数量以回购期满或回购完成时实际回购的股份数量为准。回购股份 实施期限为自公司董事会审议通过本次回购股份方案之日起 12 个月内。具体内容详见公司 于 2025 年 4 月 12 日在指定信息披露媒体及巨潮资讯网（http://www.cninfo.com.cn）披露的 《第三届董事会第十九次会议决议公告》（公告编号：2025-0 ...

关于回购公司股份事项前十名股东持股信息的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 证券代码：001206 证券简称：依依股份 公告编号：2025-013 天津市依依卫生用品股份有限公司 天津市依依卫生用品股份有限公司（以下简称"公司"）于 2025 年 4 月 11 日召开第三届董事会第十九次会议逐项审议通过了《关于回购公司股份方案的议 案》。具体内容详见公司于 2025 年 4 月 12 日发布在指定信息披露媒体及巨潮资 讯网（www.cninfo.com.cn）披露的《关于回购公司股份方案的公告暨回购报告书》 （公告编号：2025-012）。根据《上市公司股份回购规则》《深圳证券交易所上 市公司自律监管指引第 9 号——回购股份》等相关规定，现将公司董事会公告回 购股份决议前一个交易日（即 2025 年 4 月 11 日）登记在册的前十名股东和前十 名无限售条件股东的名称及持股数量、比例的情况公告如下： 一、董事会公告回购股份决议的前一个交易日（即 2025 年 4 月 11 日）前 十名股东持股情况 | 序号 | 股东名称 | 持有数量（股） ...